Search

everythinglearnresearchcommunity

for

Search:↓

Use minoxidil for hair loss treatment; assess results after 6 months.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Lower SHBG levels may increase the risk of PCOS.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

SHBG may be a useful early indicator and treatment target for PCOS.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.